​

Achieve Life Sciences (ACHV) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

ACHV Stock Forecast

Achieve Life Sciences (ACHV) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $4.75, with a high of $5.50 and a low of $4.00. This represents a 43.07% increase from the last price of $3.32.

High: $5.5 Avg: $4.75 Low: $4 Last Closed Price: $3.32

ACHV Stock Rating

Achieve Life Sciences stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

ACHV Price Target Upside V Benchmarks

TypeNameUpside
StockAchieve Life Sciences43.07%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$3.32$3.32$3.32
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2515---6
May, 2516---7
Apr, 2517---8
Mar, 2517---8
Feb, 2517---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 13, 2024Francois BriseboisOppenheimer$5.50$2.42127.27%65.66%
Nov 16, 2022Maxim Group$4.00$1.13253.98%20.48%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 26, 2024Raymond JamesStrong Buyinitialise
May 13, 2024OppenheimerOutperformOutperformhold
Dec 12, 2023OppenheimerOutperformOutperformhold
Nov 16, 2022Maxim GroupBuyBuyhold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 $2 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-4.05$-3.95$-1.50$-1.24----
Avg Forecast$-3.92$-4.07$-1.56$-1.22$-1.14$-0.61$0.19$1.90
High Forecast$-3.92$-4.07$-1.52$-1.09$-0.92$0.07$0.21$1.90
Low Forecast$-3.92$-4.07$-1.59$-1.34$-1.38$-0.92$0.11$1.90
Surprise %3.32%-2.95%-3.85%1.64%----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported--------
Avg Forecast$40.00K$100.00K--$16.42M$31.10M$92.64M$198.95M
High Forecast$40.00K$100.00K--$16.42M$31.35M$95.77M$198.95M
Low Forecast$40.00K$100.00K--$16.42M$30.85M$89.52M$198.95M
Surprise %--------

Net Income Forecast

$-100M $-70M $-40M $-10M $20M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-32.90M$-41.88M$-29.82M$-39.83M----
Avg Forecast$-77.72M$-80.60M$-30.87M$-24.01M$-22.78M$-8.43M$3.17M$37.67M
High Forecast$-77.72M$-80.60M$-30.17M$-21.52M$-18.18M$1.40M$4.23M$37.67M
Low Forecast$-77.72M$-80.60M$-31.56M$-26.49M$-27.37M$-18.26M$2.11M$37.67M
Surprise %-57.67%-48.04%-3.40%65.90%----

ACHV Forecast FAQ

Is Achieve Life Sciences stock a buy?

Achieve Life Sciences stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Achieve Life Sciences is a favorable investment for most analysts.

What is Achieve Life Sciences's price target?

Achieve Life Sciences's price target, set by 5 Wall Street analysts, averages $4.75 over the next 12 months. The price target range spans from $4 at the low end to $5.5 at the high end, suggesting a potential 43.07% change from the previous closing price of $3.32.

How does Achieve Life Sciences stock forecast compare to its benchmarks?

Achieve Life Sciences's stock forecast shows a 43.07% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Achieve Life Sciences over the past three months?

  • June 2025: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Achieve Life Sciences’s EPS forecast?

Achieve Life Sciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.14, marking a -8.06% decrease from the reported $-1.24 in 2024. Estimates for the following years are $-0.61 in 2026, $0.19 in 2027, and $1.9 in 2028.

What is Achieve Life Sciences’s revenue forecast?

Achieve Life Sciences's average annual revenue forecast for its fiscal year ending in December 2025 is $16.42M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $31.1M, followed by $92.64M for 2027, and $198.95M for 2028.

What is Achieve Life Sciences’s net income forecast?

Achieve Life Sciences's net income forecast for the fiscal year ending in December 2025 stands at $-22.775M, representing a -42.81% decrease from the reported $-39.827M in 2024. Projections indicate $-8.427M in 2026, $3.17M in 2027, and $37.67M in 2028.